These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20228039)

  • 1. Effect of drug content and agglomerate size on tabletability and drug release characteristics of bromhexine hydrochloridetalc agglomerates prepared by crystallo-co-agglomeration.
    Jadhav N; Pawar A; Paradkar A
    Acta Pharm; 2010 Mar; 60(1):25-38. PubMed ID: 20228039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix.
    Jadhav N; Pawar A; Paradkar A
    AAPS PharmSciTech; 2007 Jul; 8(3):E59. PubMed ID: 17915809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of High-Strength Extended-Release Multiparticulate System by Crystallo-co-agglomeration Technique with Integration of Central Composite Design.
    Gaikwad VL; Jadhav NR; Pawar AP; Mahadik KR
    AAPS PharmSciTech; 2019 May; 20(5):192. PubMed ID: 31115715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agglomeration of Ibuprofen with talc by novel crystallo-co-agglomeration technique.
    Pawar A; Paradkar A; Kadam S; Mahadik K
    AAPS PharmSciTech; 2004 Sep; 5(4):e55. PubMed ID: 15760052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability.
    Raval MK; Sorathiya KR; Chauhan NP; Patel JM; Parikh RK; Sheth NR
    Drug Dev Ind Pharm; 2013 Mar; 39(3):437-46. PubMed ID: 22380546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of talc agglomerates obtained by wet spherical agglomeration as a substrate for coating.
    Jadhav NR; Pawar AP; Paradkar AR
    Pharm Dev Technol; 2011 Apr; 16(2):152-61. PubMed ID: 20105058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
    Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
    AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box-Behnken experimental design.
    Garala KC; Patel JM; Dhingani AP; Dharamsi AT
    Int J Pharm; 2013 Aug; 452(1-2):135-56. PubMed ID: 23684660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of preparation method on compactability of paracetamol granules and agglomerates.
    Fichtner F; Rasmuson AC; Alander EM; Alderborn G
    Int J Pharm; 2007 May; 336(1):148-58. PubMed ID: 17196775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
    Chansanroj K; Betz G
    Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F; Rasmuson A; Alderborn G
    Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic evaluation of binary effects of magnesium stearate and talc as dissolution retardants at 85% drug loading in an experimental extended-release formulation.
    Dürig T; Fassihi R
    J Pharm Sci; 1997 Oct; 86(10):1092-8. PubMed ID: 9344163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.
    Garala K; Patel J; Patel A; Raval M; Dharamsi A
    Int J Pharm Investig; 2012 Oct; 2(4):189-200. PubMed ID: 23580935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in-vitro evaluation of sustained-release metoclopramide hydrochloride microspheres.
    Khidr SH; Niazy EM; el-Sayed YM
    J Microencapsul; 1995; 12(6):651-60. PubMed ID: 8558387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of some additives on the efficiency of binder liquid in wet agglomeration of crystals.
    Maghsoodi M; Nabizadeh H; Nokhodchi A
    Pharm Dev Technol; 2017 Sep; 22(6):827-835. PubMed ID: 27387408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel co-processing method to manufacture an API for extended release formulation via formation of agglomerates of active ingredient and hydroxypropyl methylcellulose during crystallization.
    Rosenbaum T; Erdemir D; Chang SY; Kientzler D; Wang S; Chan SH; Brown J; Hanley S; Kiang S
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1606-1612. PubMed ID: 29916275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.